Ajanta End Period Cash Flow vs Change To Operating Activities Analysis

AJANTPHARM

2,560 64.65 2.59%

Ajanta Pharma financial indicator trend analysis is way more than just evaluating Ajanta Pharma Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ajanta Pharma Limited is a good investment. Please check the relationship between Ajanta Pharma End Period Cash Flow and its Change To Operating Activities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ajanta Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

End Period Cash Flow vs Change To Operating Activities

End Period Cash Flow vs Change To Operating Activities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ajanta Pharma Limited End Period Cash Flow account and Change To Operating Activities. At this time, the significance of the direction appears to have strong relationship.

The correlation between Ajanta Pharma's End Period Cash Flow and Change To Operating Activities is 0.64. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Change To Operating Activities in the same time period over historical financial statements of Ajanta Pharma Limited, assuming nothing else is changed. The correlation between historical values of Ajanta Pharma's End Period Cash Flow and Change To Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Ajanta Pharma Limited are associated (or correlated) with its Change To Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Operating Activities has no effect on the direction of End Period Cash Flow i.e., Ajanta Pharma's End Period Cash Flow and Change To Operating Activities go up and down completely randomly.

Correlation Coefficient

0.64

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

End Period Cash Flow

Change To Operating Activities

Most indicators from Ajanta Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ajanta Pharma Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ajanta Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

The Ajanta Pharma's current Selling General Administrative is estimated to increase to about 1.6 B, while Tax Provision is projected to decrease to under 2 B.

	2022	2023	2024	2025 (projected)
Interest Expense	58.4M	72.1M	64.9M	83.5M
Depreciation And Amortization	1.3B	1.4B	1.6B	1.6B

Interest Expense Depreciation And Amortization

Ajanta Pharma fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Net Receivables	Short Term Debt	Retained Earnings	Intangible Assets	Other Liab	Net Tangible Assets
Total Assets		-0.65	0.85	0.96	1.0	0.98	-0.77	0.67	0.98	0.41	0.89	-0.72	0.64	0.98	0.24	-0.03	0.95	0.99	0.74	0.98	0.9	-0.71	0.98	0.29	0.97	0.91
Short Long Term Debt Total	-0.65		-0.44	-0.49	-0.69	-0.7	0.69	-0.4	-0.7	-0.34	-0.59	0.31	-0.17	-0.6	0.03	0.16	-0.47	-0.61	-0.46	-0.58	-0.58	0.78	-0.6	-0.14	-0.58	-0.69
Other Current Liab	0.85	-0.44		0.94	0.81	0.76	-0.78	0.78	0.77	0.21	0.97	-0.6	0.68	0.85	0.07	0.05	0.93	0.89	0.75	0.82	0.82	-0.56	0.87	0.19	0.83	0.75
Total Current Liabilities	0.96	-0.49	0.94		0.93	0.89	-0.74	0.71	0.9	0.37	0.94	-0.72	0.71	0.95	0.22	0.05	1.0	0.97	0.76	0.96	0.88	-0.58	0.96	0.3	0.94	0.83
Total Stockholder Equity	1.0	-0.69	0.81	0.93		0.99	-0.77	0.66	0.99	0.42	0.87	-0.7	0.6	0.97	0.24	-0.05	0.92	0.98	0.73	0.97	0.89	-0.74	0.97	0.27	0.97	0.92
Property Plant And Equipment Net	0.98	-0.7	0.76	0.89	0.99		-0.79	0.67	1.0	0.37	0.83	-0.63	0.55	0.95	0.32	-0.14	0.88	0.94	0.69	0.95	0.82	-0.73	0.93	0.24	0.95	0.93
Net Debt	-0.77	0.69	-0.78	-0.74	-0.77	-0.79		-0.93	-0.78	-0.08	-0.85	0.22	-0.49	-0.74	-0.24	-0.03	-0.71	-0.75	-0.61	-0.7	-0.58	0.71	-0.71	0.01	-0.74	-0.84
Cash	0.67	-0.4	0.78	0.71	0.66	0.67	-0.93		0.66	-0.05	0.79	-0.13	0.57	0.66	0.32	0.11	0.69	0.67	0.61	0.62	0.48	-0.53	0.63	-0.03	0.67	0.76
Non Current Assets Total	0.98	-0.7	0.77	0.9	0.99	1.0	-0.78	0.66		0.39	0.84	-0.65	0.57	0.96	0.3	-0.12	0.89	0.95	0.7	0.96	0.84	-0.73	0.95	0.25	0.95	0.92
Non Currrent Assets Other	0.41	-0.34	0.21	0.37	0.42	0.37	-0.08	-0.05	0.39		0.28	-0.51	0.2	0.39	0.02	0.22	0.38	0.42	0.32	0.48	0.46	-0.36	0.41	0.18	0.39	0.28
Cash And Short Term Investments	0.89	-0.59	0.97	0.94	0.87	0.83	-0.85	0.79	0.84	0.28		-0.58	0.58	0.86	0.09	0.09	0.92	0.91	0.78	0.87	0.82	-0.7	0.88	0.14	0.84	0.81
Common Stock Shares Outstanding	-0.72	0.31	-0.6	-0.72	-0.7	-0.63	0.22	-0.13	-0.65	-0.51	-0.58		-0.35	-0.72	-0.03	-0.01	-0.75	-0.75	-0.44	-0.76	-0.79	0.37	-0.76	-0.35	-0.69	-0.41
Non Current Liabilities Total	0.64	-0.17	0.68	0.71	0.6	0.55	-0.49	0.57	0.57	0.2	0.58	-0.35		0.72	0.26	0.12	0.74	0.68	0.51	0.65	0.6	-0.23	0.72	0.64	0.75	0.69
Inventory	0.98	-0.6	0.85	0.95	0.97	0.95	-0.74	0.66	0.96	0.39	0.86	-0.72	0.72		0.18	0.01	0.96	0.99	0.69	0.97	0.92	-0.66	0.99	0.36	0.99	0.9
Other Current Assets	0.24	0.03	0.07	0.22	0.24	0.32	-0.24	0.32	0.3	0.02	0.09	-0.03	0.26	0.18		-0.01	0.22	0.19	0.08	0.31	-0.15	0.1	0.18	0.33	0.29	0.29
Other Stockholder Equity	-0.03	0.16	0.05	0.05	-0.05	-0.14	-0.03	0.11	-0.12	0.22	0.09	-0.01	0.12	0.01	-0.01		0.06	0.03	-0.02	0.02	0.04	0.0	-0.02	0.06	-0.02	-0.06
Total Liab	0.95	-0.47	0.93	1.0	0.92	0.88	-0.71	0.69	0.89	0.38	0.92	-0.75	0.74	0.96	0.22	0.06		0.97	0.74	0.96	0.89	-0.55	0.97	0.35	0.94	0.82
Total Current Assets	0.99	-0.61	0.89	0.97	0.98	0.94	-0.75	0.67	0.95	0.42	0.91	-0.75	0.68	0.99	0.19	0.03	0.97		0.75	0.98	0.93	-0.68	0.99	0.32	0.97	0.88
Common Stock	0.74	-0.46	0.75	0.76	0.73	0.69	-0.61	0.61	0.7	0.32	0.78	-0.44	0.51	0.69	0.08	-0.02	0.74	0.75		0.72	0.72	-0.59	0.71	0.16	0.65	0.77
Accounts Payable	0.98	-0.58	0.82	0.96	0.97	0.95	-0.7	0.62	0.96	0.48	0.87	-0.76	0.65	0.97	0.31	0.02	0.96	0.98	0.72		0.88	-0.66	0.97	0.36	0.96	0.87
Net Receivables	0.9	-0.58	0.82	0.88	0.89	0.82	-0.58	0.48	0.84	0.46	0.82	-0.79	0.6	0.92	-0.15	0.04	0.89	0.93	0.72	0.88		-0.71	0.93	0.27	0.86	0.76
Short Term Debt	-0.71	0.78	-0.56	-0.58	-0.74	-0.73	0.71	-0.53	-0.73	-0.36	-0.7	0.37	-0.23	-0.66	0.1	0.0	-0.55	-0.68	-0.59	-0.66	-0.71		-0.66	0.08	-0.62	-0.71
Retained Earnings	0.98	-0.6	0.87	0.96	0.97	0.93	-0.71	0.63	0.95	0.41	0.88	-0.76	0.72	0.99	0.18	-0.02	0.97	0.99	0.71	0.97	0.93	-0.66		0.39	0.98	0.88
Intangible Assets	0.29	-0.14	0.19	0.3	0.27	0.24	0.01	-0.03	0.25	0.18	0.14	-0.35	0.64	0.36	0.33	0.06	0.35	0.32	0.16	0.36	0.27	0.08	0.39		0.4	0.34
Other Liab	0.97	-0.58	0.83	0.94	0.97	0.95	-0.74	0.67	0.95	0.39	0.84	-0.69	0.75	0.99	0.29	-0.02	0.94	0.97	0.65	0.96	0.86	-0.62	0.98	0.4		0.9
Net Tangible Assets	0.91	-0.69	0.75	0.83	0.92	0.93	-0.84	0.76	0.92	0.28	0.81	-0.41	0.69	0.9	0.29	-0.06	0.82	0.88	0.77	0.87	0.76	-0.71	0.88	0.34	0.9

Click cells to compare fundamentals

Ajanta Pharma Account Relationship Matchups

Ajanta Pharma fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	37.8B	40.6B	46.8B	46.4B	53.3B	56.0B
Short Long Term Debt Total	313.6M	250.3M	356.3M	352.8M	317.5M	301.6M
Other Current Liab	1.9B	2.5B	6.6B	3.4B	3.9B	4.1B
Total Current Liabilities	6.5B	6.5B	11.4B	9.0B	10.3B	10.8B
Total Stockholder Equity	30.0B	32.6B	33.9B	35.7B	41.0B	43.1B
Property Plant And Equipment Net	16.3B	16.5B	17.0B	17.2B	19.8B	20.8B
Net Debt	(1.5B)	(1.8B)	(2.9B)	(942.1M)	(847.9M)	(805.5M)
Cash	1.8B	2.1B	3.3B	1.3B	1.5B	909.4M
Non Current Assets Total	17.5B	17.9B	18.5B	19.1B	21.9B	23.0B
Non Currrent Assets Other	566.8M	497.1M	133.4M	1.5B	1.7B	1.8B
Cash And Short Term Investments	3.8B	3.3B	8.4B	4.6B	5.3B	5.5B
Common Stock Shares Outstanding	130.6M	129.7M	128.1M	126.0M	113.4M	104.9M
Liabilities And Stockholders Equity	37.8B	40.6B	46.8B	46.4B	53.3B	56.0B
Non Current Liabilities Total	1.3B	1.4B	1.5B	1.8B	1.6B	973.4M
Inventory	7.7B	7.9B	8.2B	8.3B	9.5B	10.0B
Other Current Assets	1.4B	1.3B	1.2B	2.0B	2.3B	1.4B
Other Stockholder Equity	8.2B	5.3B	2.2B	2.6M	2.3M	2.2M
Total Liab	7.8B	7.9B	12.9B	10.7B	12.3B	12.9B
Total Current Assets	20.3B	22.6B	28.3B	27.3B	31.4B	33.0B
Accumulated Other Comprehensive Income	8.2B	5.3B	2.2B	2.3B	2.6B	2.7B
Common Stock	173.9M	171.7M	252.7M	251.8M	289.6M	173.1M
Accounts Payable	3.7B	3.3B	4.2B	4.6B	5.3B	5.6B
Net Receivables	7.4B	10.2B	10.6B	12.5B	14.3B	15.1B
Short Term Debt	115.9M	64.6M	94.3M	117.6M	105.8M	100.5M
Retained Earnings	21.6B	27.2B	31.4B	33.1B	38.1B	40.0B
Intangible Assets	107.9M	90.2M	77.5M	146.6M	168.6M	95.3M
Other Liab	726.7M	1.0B	1.1B	1.3B	1.4B	1.5B
Net Tangible Assets	22.4B	25.9B	29.8B	32.6B	37.4B	21.1B
Other Assets	664.4M	1.1B	1.1B	1.1B	1.3B	797.3M
Long Term Debt	6.6M	7.4M	16M	16.4M	12.5M	0.0
Short Term Investments	2.0B	1.2B	5.1B	3.3B	3.8B	4.0B
Short Long Term Debt	900K	2.7M	1.8M	14.9M	13.4M	12.7M
Property Plant Equipment	15.8B	16.3B	16.5B	17.0B	19.5B	12.7B
Current Deferred Revenue	2.3B	2.5B	6.8B	393.2M	452.2M	429.6M
Long Term Debt Total	127.1M	197.7M	185.7M	262M	301.3M	316.4M
Non Current Liabilities Other	33.4M	30M	26.7M	23.4M	26.9M	27.5M
Net Invested Capital	30.0B	32.7B	33.9B	35.7B	41.0B	31.7B
Net Working Capital	13.8B	16.2B	16.9B	18.4B	21.1B	14.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Other Information on Investing in Ajanta Stock

Balance Sheet is a snapshot of the financial position of Ajanta Pharma Limited at a specified time, usually calculated after every quarter, six months, or one year. Ajanta Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ajanta Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ajanta currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ajanta End Period Cash Flow vs Change To Operating Activities Analysis

End Period Cash Flow vs Change To Operating Activities

End Period Cash Flow vs Change To Operating Activities Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Change To Operating Activities

Ajanta Pharma fundamental ratios Correlations

Ajanta Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ajanta Pharma fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Ajanta Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.99	Total Stockholder Equity

Cash	- 0.93	Net Debt
Cash And Short Term Investments	- 0.85	Net Debt
Net Tangible Assets	- 0.84	Net Debt
Net Receivables	- 0.79	Common Stock Shares Outstanding
Net Debt	- 0.79	Property Plant And Equipment Net
Non Current Assets Total	- 0.78	Net Debt